Updated:
7 Health Ventures
7 Health Ventures is a venture capital; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
Overview
7 Health Ventures is an exempt reporting adviser, established in 2026. It advises clients on healthcare investments.
General information
Firm type
Venture Capital
Sector focus
Frequently asked questions
What investment stages does 7 Health Ventures target?
The firm concentrates on seed and Series A stages, where its domain expertise and operator networks can materially influence early company formation. This conviction-stage approach allows for meaningful engagement with founding teams as they navigate healthcare's regulatory and reimbursement complexity. Later-stage and growth-equity opportunities fall outside the firm's disclosed mandate.
Which sectors does 7 Health Ventures explicitly avoid?
The firm's mandate excludes biotech, pharmaceuticals, medical devices, diagnostics hardware, and general SaaS platforms with no healthcare-specific workflow integration. This negative screen distinguishes it from broad-spectrum healthtech funds that mix therapeutics, devices, and software under one strategy.
How does 7 Health Ventures source investment opportunities?
Sourcing relies on domain-specific operator networks within healthcare delivery organizations, payer systems, and health system innovation groups. The firm's singular industry focus creates referral density from clinicians-turned-founders and health system executives. No proprietary data platform or public deal-flow disclosure mechanism has been identified in available records.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: